Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s Net Profit Dropped 3.1% in First Quarter of 2022

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (上海复旦张江生物医药股份有限公司) (688505.SH) reported a net profit of 4.8 million yuan in the first quarter of 2022, down 3.1% year-on-year.

Meanwhile, the company posted 140.8 million yuan in revenue, up 11.6% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 522.4 million yuan in total liabilities, with a liability-to-asset ratio of 19.3%.